CrisprBits

Private

DelhiHealthcare & Life Scienceshttps://crisprbits.com/

Last Round

Series A

Nov 25, 2025

Est. Valuation

$12M

Total Funding Raised

$3.25M

Company Overview

CrisprBits is a biotechnology company that develops diagnostic tests and gene-editing technology platforms for healthcare, food safety, and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Revenue Share, Hardware Sales

AI Layer

Infrastructure

Keywords

CRISPR diagnosticsgene editingmolecular diagnosticspoint-of-need diagnosticspoint-of-care testingrapid diagnostic testsPOCTstrain engineeringsynthetic biologysynbioindustrial biotechnologyantimicrobial resistance testingsickle cell disease diagnosticsfood safety testinganimal health diagnosticsbiofuel productionrare disease therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CrisprBits Comps

Public and private peers based on sector, stage, and business model.

CrisprBits comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CrisprBits Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 25, 2025
Pre Seed	Feb 13, 2023

View all Funding Rounds

CrisprBits Investors

Notable investors and investment history

CrisprBits investors
Investor	Rounds
Spectrum Impact	Series A
Centre for Cellular and Molecular Platforms	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 25, 2025
Grew 27% QoQ, from 22 to 28 employees.
Jul 21, 2025
Grew 30% QoQ, from 20 to 26 employees.

View all signals

CrisprBits Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CrisprBits Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CrisprBits's valuation, stock price, and market status.

Firmographic Details

HeadquartersDelhi

Employee Range28

Year Founded2020

Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.